Exercise and Nutritional Intervention in Older Adults With Sarcopenia (Spleen-Kidney Deficiency Pattern)
A Prospective Single-Arm Cohort Study of Exercise and Nutritional Intervention in Older Adults With Sarcopenia (Spleen-Kidney Deficiency Pattern)
This study will enroll older adults with sarcopenia (Spleen-Kidney Deficiency Pattern) who will receive exercise and nutritional interventions. By assessing changes from baseline in DXA-measured appendicular muscle mass and other efficacy outcomes, the study aims to characterize the longitudinal changes in sarcopenia over a 24-week period and provide an external control for a future randomized, double-blind clinical trial of Peiyuan Guben Tongluo Ointment in older adults with sarcopenia (Spleen-Kidney Deficiency Pattern).
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Xiao ya Zhang, Undergraduate
- Telefonnummer: +86 13645337890
- E-post: 2365672026@qq.com
Studiesteder
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, Kina, 200437
- Rekruttering
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Patients aged ≥ 60 and ≤ 90 years, regardless of sex.
- Meet the diagnostic criteria for sarcopenia in older adults according to both Western medicine and traditional Chinese medicine (TCM).
- Meet the TCM diagnostic criteria for the Spleen-Kidney Deficiency Pattern.
- Be willing to comply with the study intervention protocol, attend scheduled follow-up visits, and provide written informed consent.
Exclusion Criteria:
- Patients with severe cerebrovascular diseases resulting in quadriplegia, long-term bedridden status, or complete loss of muscle strength (Grade 0); patients with muscle atrophy caused by various factors; or those unable to perform activities of daily living independently.
- Patients with Alzheimer's disease or vascular dementia accompanied by impaired consciousness, aphasia, delirium, inability to communicate or respond appropriately, or disorientation to time, place, or person.
- Patients with severe psychiatric disorders or depressive conditions who are receiving relevant pharmacological treatment.
- Patients with comorbid conditions that may affect nutritional status, including malignancies, severe infections, gastrointestinal bleeding, hepatic or renal insufficiency, or cardiac insufficiency.
- Patients who have received or are currently receiving traditional Chinese medicine treatment within the past month, or who have received medications affecting muscle contraction or relaxation within the past month.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
DXA-measured appendicular skeletal muscle mass
Tidsramme: Baseline, week 12, week 24
|
Detected by dual-energy X-ray absorptiometry (GE Healthcare, DXA). The skeletal muscle mass index (SMI) is defined as the ratio of DXA-measured skeletal muscle mass to the square of height. |
Baseline, week 12, week 24
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Upper limb handgrip strength
Tidsramme: Up to 24 weeks
|
Use a hand dynamometer to record grip strength data for comparison. |
Up to 24 weeks
|
|
Handgrip strength
Tidsramme: Baseline, week 12, week 24
|
Use a hand dynamometer to record grip strength data for comparison. |
Baseline, week 12, week 24
|
|
Timed Up and Go test (TUG)
Tidsramme: Baseline, week 12, week 24
|
Subjects shall sit on a chair with a seat height of 46 cm, a straight backrest and armrests (armrest height approximately 65 cm). They are required to stand up with minimal assistance from the armrests. The total time is recorded from leaving the backrest to standing upright, walking 3 meters at their usual walking speed, turning around, walking back, and sitting down fully against the chair back. The average value of three trials is calculated. Elderly individuals who routinely use walking aids may use them during the test. |
Baseline, week 12, week 24
|
|
Berg Balance Scale (BBS)
Tidsramme: Baseline, week 12, week 24
|
The scale consists of 14 items in total, including sitting to standing, standing to sitting, standing unsupported, standing with eyes closed, reaching forward with outstretched arms, turning 360 degrees, alternating foot placement on a step, single-leg standing, etc. All items take 10-15 minutes to complete. Each item is scored from a minimum of 0 points to a maximum of 4 points, with a total possible score of 56 points. A higher score indicates better balance function; a score below 40 points suggests an increased risk of falls. |
Baseline, week 12, week 24
|
|
TCM Syndrome Score
Tidsramme: Baseline, week 12, week 24
|
In accordance with the scoring criteria specified in the 《Guiding Principles for Clinical Research of New Traditional Chinese Medicine Drugs》, the total score for **Spleen-Kidney Deficiency Syndrome** was calculated. |
Baseline, week 12, week 24
|
|
Mini Nutritional Assessment (MNA)
Tidsramme: Baseline, week 12, week 24
|
Nutritional status was evaluated using the Mini Nutritional Assessment (MNA). This scale comprehensively evaluates an individual's nutritional status through a series of questions covering body weight, dietary intake, mobility, mental state and other aspects. The full score of the scale is 30 points. Grading criteria: a total score ≥ 24 indicates good nutritional status; a score between 17 and 24 suggests risk of malnutrition; a total score below 17 confirms definite malnutrition. |
Baseline, week 12, week 24
|
|
Activities of Daily Living (ADL) Scale
Tidsramme: Baseline. week 12, week 24
|
The Activities of Daily Living (ADL) scale, developed by American scholars Lawton and Brody in 1969, is a medical assessment tool composed of the Physical Self-Maintenance Scale (PSMS) and the Instrumental Activities of Daily Living (IADL). It is mainly used to evaluate subjects' functional levels in basic living skills such as feeding, dressing and mobility, as well as the ability to use instrumental tools. Constructed from two dimensions including PSMS and IADL, the scale contains a total of 10 assessment items. |
Baseline. week 12, week 24
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Fenghua Qian, Undergraduate, Shanghai Yueyang Integrated Medicine Hospital
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- YY-PYGBTLG-002
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .